# Exploring nutraceutical approaches linking metabolic syndrome and cognitive impairment

## TL;DR

This paper reviews how nutraceuticals may help manage both metabolic syndrome and cognitive impairment by targeting shared pathways like inflammation and oxidative stress.

## Contribution

The paper provides a review of clinical evidence on nutraceuticals for managing metabolic-cognitive syndrome.

## Key findings

- Nutraceuticals may address shared mechanisms like inflammation and oxidative stress in metabolic syndrome and cognitive impairment.
- They could complement lifestyle changes in managing these interconnected conditions.

## Abstract

Metabolic syndrome (MetS) and mild cognitive impairment (MCI) are interconnected conditions sharing common pathological pathways, such as inflammation and oxidative stress, leading to the concept of “metabolic-cognitive syndrome.” This highlights their mutual influence and potential overlapping therapeutic strategies. Although lifestyle modifications remain essential, nutraceutical supplementation has emerged as a promising adjunct for the prevention and management of these preclinical conditions. This review examines clinical and translational evidence on commonly used nutraceuticals targeting shared pathophysiological mechanisms of MetS and MCI. By addressing inflammation, oxidative stress, and metabolic dysfunction, these supplements may offer a valuable approach to mitigating the progression and consequences of both conditions. Understanding their efficacy could provide practical tools to complement lifestyle changes, offering a more comprehensive strategy for managing metabolic-cognitive syndrome.

Cognitive neuroscience; Human metabolism